These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9665446)
1. Detection of H-ras mutations in urine sediments by a mutant-enriched PCR technique. Conejo JR; Parra T; Cantero M; Jiménez A; Granizo V; de Arriba G; Carballo F Clin Chem; 1998 Jul; 44(7):1570-2. PubMed ID: 9665446 [No Abstract] [Full Text] [Related]
2. Ras oncogene mutations in urine sediments of patients with bladder cancer. Buyru N; Tigli H; Ozcan F; Dalay N J Biochem Mol Biol; 2003 Jul; 36(4):399-402. PubMed ID: 12895299 [TBL] [Abstract][Full Text] [Related]
3. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. Fitzgerald JM; Ramchurren N; Rieger K; Levesque P; Silverman M; Libertino JA; Summerhayes IC J Natl Cancer Inst; 1995 Jan; 87(2):129-33. PubMed ID: 7707384 [TBL] [Abstract][Full Text] [Related]
4. Detection of tumor-derived DNA in exfoliated cells of urine sediments with a novel quantitative PCR method based on allele-specific PCR. Yamada H; Kakehi Y; Okuno H; Yoshida O Cancer Lett; 1998 Apr; 126(1):111-8. PubMed ID: 9563656 [TBL] [Abstract][Full Text] [Related]
5. Screening of human bladder tumors and urine sediments for the presence of H-ras mutations. Levesque P; Ramchurren N; Saini K; Joyce A; Libertino J; Summerhayes IC Int J Cancer; 1993 Nov; 55(5):785-90. PubMed ID: 7902340 [TBL] [Abstract][Full Text] [Related]
6. Detection of K-ras point mutation by enriched PCR-colorimetric plate assay. Santiago FS; Todd AV; Hawkins NJ; Ward RL Mol Cell Probes; 1997 Feb; 11(1):33-8. PubMed ID: 9076712 [TBL] [Abstract][Full Text] [Related]
7. A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61. Hong SJ; Lee T; Park YS; Lee KO; Chung BH; Lee SH Yonsei Med J; 1996 Dec; 37(6):371-9. PubMed ID: 9048488 [TBL] [Abstract][Full Text] [Related]
8. Screening of H-ras gene point mutations in 50 cases of bladder carcinoma. Saito S; Hata M; Fukuyama R; Sakai K; Kudoh J; Tazaki H; Shimizu N Int J Urol; 1997 Mar; 4(2):178-85. PubMed ID: 9179693 [TBL] [Abstract][Full Text] [Related]
9. High sensitive approach for point mutation detection based on electrochemiluminescence. Zhu D; Xing D; Shen X; Liu J; Chen Q Biosens Bioelectron; 2004 Oct; 20(3):448-53. PubMed ID: 15494224 [TBL] [Abstract][Full Text] [Related]
10. Activation of RAS family genes in urothelial carcinoma. Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097 [TBL] [Abstract][Full Text] [Related]
11. [Detection of G-->T mutation at codon 12 of H-ras oncogenes in gastric cancers with polymerase chain reaction and oligodeoxynucleotide(PCR-ODN)]. Liu XF Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):364-7. PubMed ID: 1299531 [TBL] [Abstract][Full Text] [Related]
12. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989 [TBL] [Abstract][Full Text] [Related]
13. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids. Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889 [TBL] [Abstract][Full Text] [Related]
14. Multiplex polymerase chain reaction amplification and direct sequencing of homologous sequences: point mutation analysis of the ras genes. Manam S; Nichols WW Anal Biochem; 1991 Nov; 199(1):106-11. PubMed ID: 1807152 [TBL] [Abstract][Full Text] [Related]
15. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Motojima K; Urano T; Nagata Y; Shiku H; Tsurifune T; Kanematsu T Ann Surg; 1993 Feb; 217(2):138-43. PubMed ID: 8439212 [TBL] [Abstract][Full Text] [Related]
16. [Detection of K-ras oncogene mutations in human lung cancer by PCR-SSCP-DNA direct sequencing]. Fang Q; Li X; Li J; Liang S Wei Sheng Yan Jiu; 1998 Jan; 27(1):6-8. PubMed ID: 10682630 [TBL] [Abstract][Full Text] [Related]
17. A possible noninvasive method for the detection of bladder cancer in patients: microsatellite analysis of free DNA in urine and blood. Utting M; Werner W; Müller G; Schubert J; Junker K Ann N Y Acad Sci; 2001 Sep; 945():31-5. PubMed ID: 11708492 [TBL] [Abstract][Full Text] [Related]
18. Activated H-ras gene mutations in transitional cell carcinoma of urinary bladder in a Kashmiri population. Pandith AA; Shah Z; Rasool R; Dil-Afroze ; Yousuf A; Parveen N; Wani S; Siddiqi M Tumori; 2010; 96(6):993-8. PubMed ID: 21388064 [TBL] [Abstract][Full Text] [Related]
19. Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR. Toyooka S; Tsukuda K; Ouchida M; Tanino M; Inaki Y; Kobayashi K; Yano M; Soh J; Kobatake T; Shimizu N; Shimizu K Oncol Rep; 2003; 10(5):1455-9. PubMed ID: 12883723 [TBL] [Abstract][Full Text] [Related]
20. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Fliss MS; Usadel H; Caballero OL; Wu L; Buta MR; Eleff SM; Jen J; Sidransky D Science; 2000 Mar; 287(5460):2017-9. PubMed ID: 10720328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]